• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

背景实质强化对磁共振成像检测乳腺癌的影响。

Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.

机构信息

DIM, Interdisciplinary Department of Medicine, Section of Diagnostic Imaging, University of Bari Medical School, Bari, Italy.

DIM, Interdisciplinary Department of Medicine, Section of Diagnostic Imaging, University of Bari Medical School, Bari, Italy.

出版信息

Diagn Interv Imaging. 2016 Mar;97(3):315-20. doi: 10.1016/j.diii.2015.12.006. Epub 2016 Mar 10.

DOI:10.1016/j.diii.2015.12.006
PMID:26970658
Abstract

OBJECTIVE

To investigate whether background parenchymal enhancement (BPE) may influence the sensitivity of dynamic contrast-enhanced magnetic resonance (DCE-MR) imaging in breast cancer detection.

MATERIALS AND METHODS

A total of 180 consecutive women with 194 breast cancers underwent MR imaging examination. Women were assigned to two different groups depending on the degree of BPE. Group 1 consisted of women with minimal or mild BPE and group 2 of women with moderate or marked BPE. The distributions of histotypes of tumors within the two groups were compared using the χ(2) test. Difference in sensitivities of DCE-MR imaging for tumor detection between the two groups was searched for using the Student t-test.

RESULTS

No differences in terms of distributions of histotypes of tumors between the two groups of women were found (P=0.5). The 11% difference in sensitivity of DCE-MR imaging for tumor detection between group 1 (91/92; 99%; 95% CI: 94-100%) and group 2 (90/102; 88%; 95% CI: 80-94%) was statistically significant (P=0.0058).

CONCLUSION

The sensitivity of DCE-MR imaging is significantly lower in women with moderate and marked BPE as compared with women with minimal and mild BPE regardless of cancer histotype. BPE could represent a limitation for breast MR imaging interpretation and should be indicated in MR imaging reports.

摘要

目的

研究背景实质强化(BPE)是否会影响乳腺癌检测中动态对比增强磁共振(DCE-MR)成像的敏感性。

材料与方法

共 180 例连续的 194 例乳腺癌女性患者接受了磁共振成像检查。根据 BPE 的程度将女性分为两组。组 1 为 BPE 轻微或轻度的女性,组 2 为 BPE 中度或重度的女性。采用卡方检验比较两组肿瘤组织学类型的分布。采用 t 检验比较两组 DCE-MR 成像检测肿瘤的敏感性差异。

结果

两组女性肿瘤组织学类型的分布无差异(P=0.5)。组 1(91/92;99%;95%可信区间:94-100%)和组 2(90/102;88%;95%可信区间:80-94%)的 DCE-MR 成像检测肿瘤的敏感性差异为 11%,具有统计学意义(P=0.0058)。

结论

与 BPE 轻微或轻度的女性相比,BPE 中度和重度的女性的 DCE-MR 成像敏感性显著降低,与癌症组织学类型无关。BPE 可能是乳腺磁共振成像解释的一个限制因素,应在磁共振成像报告中注明。

相似文献

1
Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging.背景实质强化对磁共振成像检测乳腺癌的影响。
Diagn Interv Imaging. 2016 Mar;97(3):315-20. doi: 10.1016/j.diii.2015.12.006. Epub 2016 Mar 10.
2
Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.背景实质强化对社区实践中乳腺磁共振成像解读性能的影响。
Radiology. 2018 Mar;286(3):822-829. doi: 10.1148/radiol.2017170811. Epub 2017 Oct 25.
3
Breast Background Parenchymal Enhancement on Screening Magnetic Resonance Imaging in Women Who Received Chest Radiotherapy for Childhood Hodgkin's Lymphoma.接受儿童霍奇金淋巴瘤胸部放疗的女性在乳腺磁共振成像筛查中的乳腺背景实质强化情况
Acad Radiol. 2016 Feb;23(2):168-75. doi: 10.1016/j.acra.2015.09.010. Epub 2015 Nov 3.
4
Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer.乳腺磁共振成像背景实质强化(BPE)与乳腺癌风险相关。
Magn Reson Imaging. 2016 Feb;34(2):173-6. doi: 10.1016/j.mri.2015.10.014. Epub 2015 Oct 24.
5
Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.背景实质增强在乳腺磁共振成像中的表现:正常模式、诊断挑战,以及假阳性和假阴性解读的潜在可能性。
Radiographics. 2014 Jan-Feb;34(1):234-47. doi: 10.1148/rg.341135034.
6
Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging.芳香酶抑制剂对乳腺磁共振成像中背景实质强化和纤维腺体组织量的影响。
Radiology. 2012 Sep;264(3):670-8. doi: 10.1148/radiol.12112669. Epub 2012 Jul 6.
7
Repeated surgeries in invasive lobular breast cancer with preoperative MRI: Role of additional carcinoma in situ and background parenchymal enhancement.浸润性小叶癌术前MRI引导下的重复手术:原位癌及背景实质强化的作用
Eur J Radiol. 2017 May;90:181-187. doi: 10.1016/j.ejrad.2017.02.045. Epub 2017 Mar 2.
8
Diagnostic Performance of and Breast Tissue Changes at Early Breast MR Imaging Surveillance in Women after Breast Conservation Therapy.保乳治疗后女性早期乳腺磁共振成像监测的诊断性能及乳腺组织变化。
Radiology. 2017 Sep;284(3):656-666. doi: 10.1148/radiol.2017162123. Epub 2017 Apr 18.
9
Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.背景实质强化对术前乳腺磁共振成像的影响:其如何影响解读以及二次超声检查在患者管理中的作用
Ultrasound Med Biol. 2016 Dec;42(12):2766-2774. doi: 10.1016/j.ultrasmedbio.2016.08.008. Epub 2016 Sep 19.
10
Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.对比增强光谱乳腺摄影与乳腺磁共振成像背景实质强化的比较。
Radiology. 2017 Jan;282(1):63-73. doi: 10.1148/radiol.2016160284. Epub 2016 Jul 4.

引用本文的文献

1
Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors: Evaluating Background Parenchymal Enhancement and Radiotherapy-Induced Toxicity.霍奇金淋巴瘤幸存者的长期乳腺癌风险:评估背景实质强化和放疗诱导的毒性
Cancers (Basel). 2024 Dec 6;16(23):4091. doi: 10.3390/cancers16234091.
2
MRI Evaluation of Mass-Like and None-Mass-Like-Proven Breast Cancer from Moderate-to-High Background Enhancement.基于中到高背景强化的实性及非实性乳腺癌的MRI评估
Adv Biomed Res. 2024 Apr 27;13:36. doi: 10.4103/abr.abr_221_21. eCollection 2024.
3
Background parenchymal enhancement on contrast-enhanced mammography: associations with breast density and patient's characteristics.
背景实质增强在对比增强乳腺摄影中的表现:与乳腺密度和患者特征的关系。
Radiol Med. 2024 Sep;129(9):1303-1312. doi: 10.1007/s11547-024-01860-5. Epub 2024 Jul 26.
4
Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms.预测乳腺癌患者新辅助化疗的病理完全缓解:使用来自三个区域的 MRI 放射组学数据和多种机器学习算法。
J Cancer Res Clin Oncol. 2024 Mar 21;150(3):147. doi: 10.1007/s00432-024-05680-y.
5
Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue.基于肿瘤内和衍生组织的放射组学列线图预测乳腺癌新辅助化疗病理完全缓解
BMC Med Imaging. 2024 Jan 20;24(1):22. doi: 10.1186/s12880-024-01198-4.
6
ML-DSTnet: A Novel Hybrid Model for Breast Cancer Diagnosis Improvement Based on Image Processing Using Machine Learning and Dempster-Shafer Theory.ML-DSTnet:一种基于机器学习和证据理论的图像处理的新型混合模型,用于改善乳腺癌诊断。
Comput Intell Neurosci. 2023 Nov 2;2023:7510419. doi: 10.1155/2023/7510419. eCollection 2023.
7
Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement.凯泽评分在诊断背景实质强化程度较高患者乳腺动态对比增强磁共振成像中的定量评估
Quant Imaging Med Surg. 2023 Oct 1;13(10):6384-6394. doi: 10.21037/qims-23-113. Epub 2023 Aug 17.
8
The Role of Diffusion-Weighted Imaging Based on Maximum-Intensity Projection in Young Patients with Marked Background Parenchymal Enhancement on Contrast-Enhanced Breast MRI.基于最大强度投影的扩散加权成像在乳腺对比增强磁共振成像中背景实质明显强化的年轻患者中的作用
Life (Basel). 2023 Aug 14;13(8):1744. doi: 10.3390/life13081744.
9
Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score.背景:乳腺MRI实质强化作为一种预后替代指标:与乳腺癌Oncotype Dx评分的相关性
Front Oncol. 2021 Feb 4;10:595820. doi: 10.3389/fonc.2020.595820. eCollection 2020.
10
A Gradient-Based Approach for Breast DCE-MRI Analysis.基于梯度的乳腺 DCE-MRI 分析方法。
Biomed Res Int. 2018 May 16;2018:9032408. doi: 10.1155/2018/9032408. eCollection 2018.